Furthermore, there are no specific recommendations or guidelines for treating cardiovascular disease in females compared to males, including cardiovascular therapies with recognized sex differences such as those targeting the renin–angiotensin system [39]. This evidence concerns the gene REN and cardiovascular disorder.